Filing Details

Accession Number:
0001104659-20-081337
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-06 17:24:22
Reporting Period:
2020-07-01
Accepted Time:
2020-07-06 17:24:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1280600 Acceleron Pharma Inc XLRN Pharmaceutical Preparations (2834) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
14272 Bristol Myers Squibb Co 430 E. 29Th Street
14 Floor
New York NY 10016
No No Yes No
816284 Celgene Corp /De/ 86 Morris Avenue
Summit NJ 07901
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-01 108,108 $92.50 6,971,772 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This statement is being filed jointly by Celgene Corporation and Bristol-Myers Squibb Company.
  2. These shares are owned directly by Celgene Corporation, which is a wholly owned subsidiary of Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is an indirect beneficial owner of the reported securities.